Michael Brainin

Michael Brainin

Auto-generated profile, based on publicly available information

Michael Brainin

Department of Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in International Journal of Stroke
Verified
Journal Article
Open access
PDF file
VFValery L Feigin
Valery L Feigin
MBMichael Brainin
Michael Brainin
BNBo Norrving
Bo Norrving
SMSheila Martins
Sheila Martins
RSRalph L Sacco
Ralph L Sacco
PLPatrice Lindsay
Patrice Lindsay
Stroke remains the second-leading cause of death and the third-leading cause of death and disability combined (as expressed by disability-adjusted life-years lost – DALYs) in the world. The estimated global cost of stroke is over US$721 billion (0.66% of the global GDP). From 1990 to 2019, the burden (in terms of the absolute number of cases) increased substantially (70.0% increase in incident strokes, 43.0% deaths from stroke, 102.0% prevalent strokes, and 143.0% DALYs), with the bulk of the global stroke burden (86.0% of deaths and 89.0% of DALYs) residing in lower-income and lower-middle-income countries (LMIC). This World Stroke Organisation (WSO) Global Stroke Fact Sheet 2022 provides the most updated information that can be used to inform communication with all internal and external stakeholders; all statistics have been reviewed and approved for use by the WSO Executive Committee as well as leaders from the Global Burden of Disease research group.

3 January 2025 in International Journal of Stroke
Verified
Journal Article
Open access
VFValery L Feigin
Valery L Feigin
MBMichael Brainin
Michael Brainin
BNBo Norrving
Bo Norrving
SMSheila O Martins
Sheila O Martins
JPJeyaraj Pandian
Jeyaraj Pandian
IRIlari Rautalin
Ilari Rautalin
Background: Among non-communicable disorders (NCDs), stroke remains the second leading cause of death and the third leading cause of death and disability combined (as expressed by disability-adjusted life-years lost—DALYs) in the world. Aims: The study was aimed to estimate global, regional and nationa burden of stroke and its risk factors from 1990 to 2021. Methods: Finding presented in this paper were derived mainly from the Global Burden of Disease 2021 Study on stroke burden published in The Lancet Neurology 2024:23:973-1003. Results: The estimated global cost of stroke is over US$890 billion (0.66% of the global GDP). From 1990 to 2021, the burden (in terms of the absolute number of cases) increased substantially (70.0% increase in incident strokes, 44.0% deaths from stroke, 86.0% prevalent strokes, and 32% DALYs), with the bulk of the global stroke burden (87.0% of deaths and 89.0% of DALYs) residing in lower-income and lower-middle-income countries (LMICs). Stroke attributable to metabolic risks constituted 69.0% of all strokes, environmental risks constituted 37.0%, and behavioral risks constituted 35.0%. Conclusion: This World Stroke Organization (WSO) Global Stroke Fact Sheet 2025 provides the most updated information that can be used to inform communication with all internal and external stakeholders; all statistics have been reviewed and approved for use by the WSO Executive Committee and leaders from the Global Burden of Disease research group.

15 September 2004 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
MBM. Brainin
M. Brainin
MBM. Barnes
M. Barnes
Claude BaronClaude Baron
Claude Baron
NGN. E. Gilhus
N. E. Gilhus
RHR. Hughes
R. Hughes
GWG. Waldemar
G. Waldemar
Since the publication of the first EFNS task force reports in 1997, a total of 20 evidence‐based guidelines for the treatment and management of neurological diseases have been published by the EFNS (http://www.efns.org/guidelines). In 2001, recommendations for the preparation of neurological guidelines were issued by the EFNS Scientific Committee (Eur J Neurol 2001; 8: 549–550). These have now been updated and revised. More unified criteria for standards of reporting are set up which include classes of scientific evidence and predefined levels of recommendation. These criteria as well as others listed below should be used for all working groups that aim at recommending treatment, diagnostic procedures or other interventions within the framework of the EFNS.

9 December 2014 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MBM. Brainin
M. Brainin
JTJ. Tuomilehto
J. Tuomilehto
WHW.‐D. Heiss
W.‐D. Heiss
NBN. M. Bornstein
N. M. Bornstein
PBP. M. W. Bath
P. M. W. Bath
TGthe Post Stroke Cognition Study Group
the Post Stroke Cognition Study Group

1 June 2007 in The Lancet Neurology
Verified
Journal Article
Closed access
MBMichael Brainin
Michael Brainin
YTYvonne Teuschl
Yvonne Teuschl
LKLalit Kalra
Lalit Kalra

1 June 2010 in International Journal of Stroke
Verified
Journal Article
Closed access
YTYvonne Teuschl
Yvonne Teuschl
MBMichael Brainin
Michael Brainin